-2%
Zeptide is recommended as an add-on to diet and physical activity to help regulate blood sugar levels in adults with type 2 diabetes mellitus.
- Not evaluated in patients with a history of pancreatitis.
- Not approved for patients with type 1 diabetes.
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors. It is a modified 39-amino acid peptide with a C20 fatty acid chain that binds to albumin, extending its half-life. It activates both GIP and GLP-1 receptors—natural incretin targets—enhancing insulin release during both early and late phases and reducing glucagon secretion, all in a glucose-dependent manner.
